跳至主要内容
临床试验/IRCT20210518051335N1
IRCT20210518051335N1尚未招募2 期

Evaluation and comparison of the efficacy of triple therapies regimens containing bismuth with high dose and different doses of amoxicillin for eradicating Helicobacter pylori infection

Mazandaran University of Medical Sciences0 个研究点目标入组 200 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Patients have H. pylori eradication indication based on endoscopic evidence
  • Patients with positive Rapid urease test
  • Patients with positive histology of H. pylori infection

排除标准

  • Age under 18 years
  • Reluctance to participate in the study
  • Pregnancy and lactation
  • Patients taking concomitant anticoagulants, corticosteroids or ketoconazole.
  • Patients with a history of gastric surgery
  • Patients with a history of heart failure, lung disease, chronic kidney failure, liver disease (cirrhosis or chronic hepatitis for any reason), or a history of cancer
  • Consumption of alcohol in any amount
  • The presence of any type of malignancy
  • History of drug allergy to the drugs in this study
  • History of H. pylori eradication regimens at any time before this study

研究者

相似试验

Evaluation and comparison of the efficacy of triple... | 临床试验